A BCR/ABL-hIL-2 DNA Vaccine Enhances the Immune Responses in BALB/c Mice

The use of a DNA vaccine encoding the BCR/ABL fusion gene is thought to be a promising approach for patients with chronic myeloid leukemia (CML) to eradicate minimal residual disease after treatment with chemotherapy or targeted therapy. In this study, our strategy employs genetic technology to crea...

Descripción completa

Detalles Bibliográficos
Autores principales: Qin, Yanan, Tian, Hongxia, Wang, Guanming, Lin, Chen, Li, Yangqiu
Formato: Online Artículo Texto
Lenguaje:English
Publicado: Hindawi Publishing Corporation 2013
Materias:
Research Article
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC3690203/
https://www.ncbi.nlm.nih.gov/pubmed/23841051
http://dx.doi.org/10.1155/2013/136492

Internet

https://www.ncbi.nlm.nih.gov/pmc/articles/PMC3690203/
https://www.ncbi.nlm.nih.gov/pubmed/23841051
http://dx.doi.org/10.1155/2013/136492

Ejemplares similares